Literature DB >> 23665995

One-pot, sequential four-component synthesis of benzo[c]pyrano[3,2-a]phenazine, bis-benzo[c]pyrano[3,2-a]phenazine and oxospiro benzo[c]pyrano[3,2-a]phenazine derivatives using 1,4-diazabicyclo[2.2.2]octane (DABCO) as an efficient and reusable solid base catalyst.

Alireza Hasaninejad1, Somayeh Firoozi.   

Abstract

1,4-Diazabicyclo[2.2.2]octane (DABCO) has been used as an efficient and reusable solid base catalyst for the one-pot, two-step, four-component synthesis of pyrano[3,2-a]phenazine derivatives by the condensation reaction of 2-hydroxy-1,4-naphthoquinone, 1,2-diamines, carbonyl compounds and alkylmalonates under conventional heating as well as microwave irradiation. This procedure has also been applied successfully for the synthesis of novel bis- benzo[c]pyrano[3,2-a]phenazine and oxospiro benzo[c]pyrano[3,2-a]phenazine derivatives. Using this procedure, all the products were obtained in good to excellent yields. The catalyst has been recovered and reused several times without any loss of reactivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23665995     DOI: 10.1007/s11030-013-9446-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  15 in total

1.  Domino Reactions in Organic Synthesis.

Authors:  Lutz F. Tietze
Journal:  Chem Rev       Date:  1996-02-01       Impact factor: 60.622

2.  Multicomponent Reactions with Isocyanides.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-09-15       Impact factor: 15.336

Review 3.  Phenazine natural products: biosynthesis, synthetic analogues, and biological activity.

Authors:  Jane Buus Laursen; John Nielsen
Journal:  Chem Rev       Date:  2004-03       Impact factor: 60.622

4.  Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.

Authors:  Swarna A Gamage; Julie A Spicer; Gordon W Rewcastle; John Milton; Sukhjit Sohal; Wendy Dangerfield; Prakash Mistry; Nigel Vicker; Peter A Charlton; William A Denny
Journal:  J Med Chem       Date:  2002-01-31       Impact factor: 7.446

5.  Schistosomiasis mansoni: blockage of cercarial skin penetration by chemical agents: i. naphthoquinones and derivatives.

Authors:  A V Pinto; M D Pinto; B Gilbert; J Pellegrino; R T Mello
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

6.  Multicomponent synthesis of poly-substituted benzo[a]pyrano[2,3-c]phenazine derivatives under microwave heating.

Authors:  Shu-Liang Wang; Fei-Yue Wu; Chuang Cheng; Ge Zhang; Yin-Ping Liu; Bo Jiang; Feng Shi; Shu-Jiang Tu
Journal:  ACS Comb Sci       Date:  2011-01-10       Impact factor: 3.784

7.  Synthesis and anti-Trypanosoma cruzi activity of β-lapachone analogues.

Authors:  Sabrina Baptista Ferreira; Kelly Salomão; Fernando de Carvalho da Silva; Antônio Ventura Pinto; Carlos Roland Kaiser; Angelo C Pinto; Vitor Francisco Ferreira; Solange L de Castro
Journal:  Eur J Med Chem       Date:  2011-03-15       Impact factor: 7.088

8.  Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine.

Authors:  M Muller; T C Sorrell
Journal:  Prostaglandins       Date:  1995 Nov-Dec

9.  Synthesis of alpha- and beta-pyran naphthoquinones as a new class of antitubercular agents.

Authors:  Sabrina B Ferreira; Fernando de Carvalho da Silva; Flávio A F M Bezerra; Maria C S Lourenço; Carlos R Kaiser; Angelo C Pinto; Vitor F Ferreira
Journal:  Arch Pharm (Weinheim)       Date:  2010-02       Impact factor: 3.751

10.  Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation.

Authors:  Heon Joo Park; Ki-Jung Ahn; Seung-Do Ahn; Eunkyung Choi; Sang Wook Lee; Brent Williams; Eun Jung Kim; Robert Griffin; Erik A Bey; William G Bornmann; Jinming Gao; Heon Jin Park; David A Boothman; Chang W Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 8.013

View more
  7 in total

1.  One-pot, sequential four-component synthesis of novel heterocyclic [3.3.3] propellane derivatives at room temperature.

Authors:  Maryam Beyrati; Alireza Hasaninejad
Journal:  RSC Adv       Date:  2018-04-17       Impact factor: 4.036

2.  An efficient and environmentally sustainable domino protocol for the synthesis of structurally diverse spiroannulated pyrimidophenazines using erbium doped TiO2 nanoparticles as a recyclable and reusable heterogeneous acid catalyst.

Authors:  Kanchan Verma; Yogesh Kumar Tailor; Sarita Khandelwal; Monu Agarwal; Esha Rushell; Yogita Kumari; Kamlendra Awasthi; Mahendra Kumar
Journal:  RSC Adv       Date:  2018-08-28       Impact factor: 4.036

3.  Multicomponent synthesis of diverse pyrano-fused benzophenazines using bifunctional thiourea-based organocatalyst in aqueous medium.

Authors:  Ruchi Bharti; Tasneem Parvin
Journal:  Mol Divers       Date:  2016-06-17       Impact factor: 2.943

Review 4.  A review on lawsone-based benzo[a]phenazin-5-ol: synthetic approaches and reactions.

Authors:  Abolfazl Olyaei; Mahdieh Sadeghpour
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

5.  Eco-friendly polyethylene glycol (PEG-400): a green reaction medium for one-pot, four-component synthesis of novel asymmetrical bis-spirooxindole derivatives at room temperature.

Authors:  Alireza Hasaninejad; Maryam Beyrati
Journal:  RSC Adv       Date:  2018-01-09       Impact factor: 3.361

6.  Multisulfonate hyperbranched polyglycerol functionalized graphene oxide as an efficient reusable catalyst for green synthesis of benzo[a]pyrano-[2,3-c]phenazines under solvent-free conditions.

Authors:  Hossein Naeimi; Maryam Farahnak Zarabi
Journal:  RSC Adv       Date:  2019-03-06       Impact factor: 4.036

7.  Introducing a green nanocatalytic process toward the synthesis of benzo[a]pyrano-[2,3-c]phenazines utilizing copper oxide quantum dot-modified core-shell magnetic mesoporous silica nanoparticles as high throughput and reusable nanocatalysts.

Authors:  Mohaddeseh Dehnavian; Abdulhamid Dehghani; Leila Moradi
Journal:  RSC Adv       Date:  2022-09-05       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.